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Abstract
Despite the pivotal role of the pancreas in hormonally-regulated pathways in the body, e.g. glucose homeostasis, the genetic mechanisms
de®ning it have for many years remained largely enigmatic. After years out of the spotlight, pancreas development has once again come to
centre stage. To a large extent, this is due to recent advances made through the detailed analysis of transgenic mice which have been
engineered to carry mutations in speci®c developmental control genes. This review speci®cally focuses on the speci®cation of the endocrine
pancreas lineage and in particular on the role of the developmental control genes Pax4 and Pax6 in the generation of speci®c endocrine cell
types. The comparison of various phenotypes of different mouse mutants affecting endocrine development supports a model in which Pax4
and Pax6 are required for the differentiation of certain endocrine cell lineages and implies a potential for acting at different levels of
endocrine development. q 2000 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
The importance of the pancreas for glucose homeostasis
and its implication in pathological states such as diabetes
mellitus had been documented already by the ancient
Greeks. It was not until the last 2 centuries that break-
throughs in the understanding of fundamental aspects of
pancreatic cell biology and pathophysiology were achieved,
for example by the identi®cation of the cellular components
of the islets of Langerhans, and the discovery by Banting
and Best in 1922 that lack of insulin is the primary reason
for elevated blood glucose levels in diabetic patients (Bant-
ing and Best, 1922; Banting et al., 1922). In addition, over
the last 2 decades, classical embryological experiments and
studies on the co-expression of pancreatic hormones led to
signi®cant progress in the understanding of pancreatic cell
lineages (Pictet and Rutter, 1972; Palmiter et al., 1987;
Teitelman and Lee, 1987; Teitelman et al., 1987, 1993;
Evans, 1989; Ohashi et al., 1991; Gittes and Rutter, 1992;
Githens, 1993). More recently, the anlage of the pancreas
has received special attention by developmental biologists
who have demonstrated that pancreas development requires
complex combinations of transcription factors in order to
control organogenesis and cell differentiation (summarized
in Kim et al., 1997; Sander and German, 1997; Edlund,
1998). In particular, the Pax family of transcription factors
is involved in the formation of many organs. Two of its
members, Pax4 and Pax6, play important roles in islet
differentiation (Sosa-Pineda et al., 1997; St-Onge et al.,
1997).
Pax genes encode key regulators which are involved in
the embryonic development of many organs including the
eyes, brain, kidney, thyroid gland, immune system, and the
pancreas (reviewed in Mansouri et al., 1996a; Dahl et al.,
1997). A number of murine and human genetic disorders are
linked to mutations in speci®c Pax genes. For example, a
mutated Pax1 gene is responsible for the murine undulated
(un) phenotype (Balling et al., 1988, 1992) and mutations in
the Pax2 gene cause the human ocular-renal syndrome
(Schimmenti et al., 1997). The murine splotch (sp) allele
and human Waardenburg syndrome type I are associated
with Pax3 (summarized in Epstein et al., 1993; Goulding
et al., 1993), whereas the murine small eye (Sey) mutant,
human aniridia, and Peter's anomaly are due to mutations in
Pax6 (Hogan et al., 1988; Hill et al., 1991; Ton et al., 1991;
Jordan et al., 1992; Grindley et al., 1995; Graw, 1996)
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(reviewed in Macdonald and Wilson, 1996; Stoykova et al.,
1996, 1997; Grindley et al., 1997; GoÈtz et al., 1998).
All nine Pax genes identi®ed thus far have been inacti-
vated in mice by targeted mutagenesis (Table 1). Their
inactivation generally results in embryonal or neonatal
death accompanied by striking developmental defects:
targeted disruption of Pax1 is associated with disturbed
skeletogenesis (Wilm et al., 1998), Pax2 knock-out mice
do not develop kidneys (Torres et al., 1995) and mice de®-
cient for the Pax3 gene have severe defects in the develop-
ing neural tube, neural crest and skeleton (Mansouri and
Gruss, 1998). Pax5 mutant mice lack mature B-cells and
show brain defects (Urbanek et al., 1994). Inactivation of
the Pax7 and Pax8 genes leads to neural crest defects and
thyroid gland dysgenesis, respectively (Mansouri et al.,
1996b, 1998). Pax9 mutant mice lack pharyngeal pouch
derivatives, teeth and show craniofacial and limb defects
(Peters et al., 1998).
In this review we concentrate on the development of the
pancreas which consists of mainly exocrine and endocrine
tissue. The exocrine tissue forms acinar glands that store and
secrete digestive enzymes into the digestive tract. The endo-
crine cells are clustered in islets of Langerhans and secrete
insulin, glucagon, somatostatin, and pancreatic polypeptide
directly into the blood stream. Although a number of tran-
scription factors have been identi®ed to play important roles
during pancreas development the molecular mechanisms
that de®ne the differentiation of endocrine cell types in
the pancreas have for many years remained largely
unknown.
It was only recently that the analysis of Pax4 and Pax6
knock-out mice revealed their important roles in the differ-
entiation of speci®c endocrine cell lineages during pancreas
development (Sosa-Pineda et al., 1997; St-Onge et al.,
1997). Whereas mice lacking the Pax4 gene do not generate
insulin-producing b-cells and somatostatin-producing d-
cells in the pancreas, Pax6-de®cient mice are unable to
form glucagon-producing a-cells (Table 1). The focus of
this review is the analysis of Pax4 and Pax6 gene function
during embryogenesis with special emphasis on the differ-
entiation of endocrine cells during pancreas development.
2. PAX4 and PAX6, two members of the paired domain
family of transcription factors
Pax4 and Pax6 were originally identi®ed in a homology
screen for paired box containing genes (Walther et al.,
1991). Paired box genes encode nuclear transcription factors
which are characterized by the presence of the paired
domain, a highly conserved sequence motif of 128 amino
acids which possesses DNA-binding activity (reviewed in
Noll, 1993). The Pax4 and Pax6 genes are more closely
related to each other than to other members of the Pax
gene family. In addition to the paired domain, both proteins
also have a homeodomain as well as a highly conserved
octapeptide (reviewed in Dahl et al., 1997). A characteristic
feature of Pax genes is that they are located at distinct
chromosomal loci and thus act independently and not in
tandem as other developmental control genes do, e.g. Hox
genes. The murine Pax4 gene is located on chromosome 6,
whereas Pax6 maps to chromosome 2 (Pilz et al., 1993;
Tamura et al., 1994).
During mouse embryogenesis, Pax6 is expressed in
various cellular populations in the eyes, nose, central
nervous system, and developing pancreas (Table 1)
(Walther and Gruss, 1991; Walther et al., 1991; Turque et
al., 1994). Analysis of the Pax6 promoter has led to the
identi®cation of various cis-acting elements which direct
expression in some of these tissues (Plaza et al., 1995; Xu
and Saunders, 1997, 1998; Sharon-Friling et al., 1998;
Kammandel et al., 1999; Xu et al., 1999). Although Pax6
is involved in the development of various organs, its role in
the developing eye has provided the greatest level of access
to elucidating its function. Homozygous Pax6 mutants of
Drosophila (eyeless, ey), mice (Small eye, Sey), and rats
(rSey) fail to develop eyes. In the heterozygous state a vari-
ety of ocular abnormalities are observed in mice (Small eye)
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Table 1
The Pax gene family and its association with mouse mutants and human syndromes
Gene Expressiona Knock-out phenotype Human syndrome
Pax1 Sclerotome, pharyngeal pouches, thymus Disturbed skeletogenesis
Pax2 Pro/mesonephros, metanephric
mesenchyme, mid/hindbrain, eye, ear
No kidneys Ocular-renal syndrome
Pax3 Dermamyotome, neural crest, CNS Neural tube, neural crest, skeletal defects Waardenburg syndrome
Pax4 Pancreas, neural tube No pancreatic b- and d-cells
Pax5 Pro B-cells, CNS No B-cells, brain defects
Pax6 Eye, pancreas, CNS Small eye, no pancreatic a-cells, brain defects Aniridia
Pax7 Neural crest, dermamyotome, CNS Neural crest defects
Pax8 Neural tube, CNS Neural crest defects, thyroid dysgenesis
Pax9 Pharyngeal pouches, mesenchyme No thymus, no parathyroid glands, no teeth,
craniofacial and limb defects
a Only prominent sites of expression are indicated. CNS, central nervous system.
and humans (aniridia and Peter's anomaly) (Hill et al., 1991;
Ton et al., 1991; Jordan et al., 1992; Quiring et al., 1994;
Grindley et al., 1995, 1997; Graw, 1996; Macdonald and
Wilson, 1996; Stoykova et al., 1996; Xu et al., 1997). Alter-
natively targeted expression of Pax6 genes from inverte-
brates and vertebrates induces the formation of ectopic
eyes in Drosophila, demonstrating the ability of Pax6 to
regulate complex developmental processes throughout
evolution (Halder et al., 1995).
In contrast to the widespread embryonic expression of
Pax6, the Pax4 gene is characterized by a very restricted
expression pattern with only a few Pax4-positive cells in the
ventral spinal cord, and in the endocrine pancreas (Table 1)
(Sosa-Pineda et al., 1997). Pax4 was ®rst identi®ed in mice
along with Pax6 and subsequently cloned in humans and
rats (Walther and Gruss, 1991; Pilz et al., 1993; Tamura et
al., 1994; Bonthron et al., 1998; Inoue et al., 1998; Tao et
al., 1998; Tokuyama et al., 1998). To date, there are no
known naturally occurring mutations of Pax4 in mice or
in humans.
3. Expression of Pax4 and Pax6 during pancreas
development
During mouse embryogenesis, the ®rst morphological
sign of pancreas formation is an epithelial evagination
near the junction of foregut and midgut in an area that
will become the duodenum. At embryonic day 9.5 (E9.5),
this epithelial evagination forms the dorsal pancreatic bud
(Wessells and Cohen, 1967; for review see Slack, 1995;
Edlund, 1998). Expression of PAX6 protein can be detected
already around E9.0 in a small subset of cells in the prepan-
creatic endoderm (Fig. 1). At E9.5, PAX6 protein is
expressed in a few cells of the pancreatic bud, some of
them co-expressing glucagon (Sander et al., 1997). In
contrast, Pax4 expression is ®rst detected in E10 embryos
in only a few cells of the pancreatic bud (Fig. 1) (Sosa-
Pineda et al., 1997; Sosa-Pineda, pers. commun.). Approxi-
mately half a day later (E10.5), the ®rst insulin-positive cells
can be detected, as the epithelial bud enlarges to develop
into a tree-like ductal system by branching and growth (Fig.
1).
Shortly after formation of the dorsal pancreatic bud, the
ventral bud arises at the ventro-lateral side of the gut tube.
By the time the ®rst acini and ducts can be distinguished
histologically in the dorsal bud (E14.5), the number of Pax4
expressing cells increases signi®cantly. Double labelling
experiments reveal a small subpopulation of insulin and
Pax4 co-expressing cells, compared to a larger cell popula-
tion exclusively expressing Pax4. The largest number of
Pax4 expressing cells is observed around E15.5, 1 day
after the onset of exocrine development (Sosa-Pineda,
pers. commun.). Pax4 and Pax6 expression has never
been detected in cells of the exocrine pancreas (Sander et
al., 1997; Sosa-Pineda et al., 1997; St-Onge et al., 1997). In
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Fig. 1. Schematic summary of an expression pro®le of pancreas markers during wild type, Pax4 knock-out, Pax6 knock-out and SeyNeu mutant pancreas
development. Expression is indicated by bars; decreased expression is indicated by narrow bars; dashes indicate assumed expression although not analyzed
during the corresponding stages. E, embryonic day; P, postnatal day; *, Sosa-Pineda, pers. commun.; #, St-Onge, pers. commun. Promoter activity was
determined by b-galactosidase staining.
contrast to the cell type restricted expression of Pax4 during
these stages, Pax6 expression is detected throughout all
endocrine cells of the developing pancreas producing
hormones. As the end of gestation approaches and all endo-
crine cells begin to organize into the typical islets of Langer-
hans, Pax6 expression is maintained, whereas Pax4
expression continually decreases. Finally, in the adult
pancreas Pax4 expression is no longer detectable (Sosa-
Pineda, pers. commun.).
In summary, expression of Pax4 and Pax6 during the
early stages of pancreas development is con®ned to cellular
subsets of the endocrine lineage. Pax6, which can be
detected throughout pancreas development, is expressed in
all endocrine cells. In contrast, Pax4 is required exclusively
in cells restricted to the b- and d-cell lineage and can only be
detected during embryogenesis.
4. The pancreas of Pax6 knock-out and Small eye
(SeyNeu) mice
Sey and SeyNeu mice carry semi-dominant Pax6 alleles
which are due to point mutations in the Pax6 locus resulting
in truncated PAX6 proteins (Hill et al., 1991; Sander et al.,
1997). In Sey mutants the protein is truncated directly after
the paired domain while in SeyNeu mice the protein is trun-
cated after the homeodomain, thus leaving both protein
domains intact. To generate complete knock-out mice, the
Pax6 start codon along with the entire paired box was
replaced with the b-galactosidase gene resulting in mutant
mice in which no protein is detectable (St-Onge et al.,
1997). In the homozygous state, SeyNeu and Pax6 knock-
out mutants lack eyes, show severe brain defects, and die
shortly after birth. However, differences in the pancreatic
defects are observed in the mutant animals. Whereas Pax6
knock-out mice do not form glucagon-producing a-cells
throughout all developmental stages, SeyNeu mice express
normal levels of glucagon during the early stages of
pancreas development (Fig. 1). A decrease in the number
of glucagon-positive cells becomes evident around E10.5,
and at E12.5 glucagon- and also insulin-positive cells are
reduced signi®cantly in SeyNeu mice (Fig. 1). Although
glucagon-producing a-cells are most strongly affected in
SeyNeu mice, all four endocrine cell types are decreased
signi®cantly in number by E18.5 (Fig. 1). In contrast,
Pax6 knock-out mice only lack cells of the a-cell lineage
(Fig. 1). Furthermore, islet morphology is disrupted in Pax6
knock-out mice. The remaining insulin-, somatostatin-, and
pancreatic polypeptide-producing cells found in Pax6
knock-out mice do not form proper spherical islet structures,
but organize in elongated, stream-like clusters. d- and g-
cells (together with a-cells) which normally form a rim
around a b-cell core, mix instead with the insulin-producing
cells in the Pax6 mutant pancreas. Insulin expression is
detectable from E13.5 onwards, and expression of Pdx1
(coding for a transcription factor with a major involvement
in islet development) appears to be normal (Fig. 1) (St-
Onge, pers. commun.). The exocrine tissue on the other
hand seems unaffected, synthesizing a-amylase. In SeyNeu
mutant mice, islet morphology is also altered although in a
more subtle manner. The initial aggregation of endocrine
cells seems unaffected and the number of developing islets
appears normal. However, SeyNeu/SeyNeu islets do not form
properly with a b-cell core and a mantle of a-, d- and PP-
cells but the cell populations appear mixed within a given
islet. Furthermore, hormone production is markedly reduced
in SeyNeu mutants, pointing to a decrease in PAX6-regulated
glucagon and insulin gene transcription. In support of this
observation, biochemical studies involving the PAX6
protein demonstrate its binding to regulatory sequence
elements of the glucagon, insulin and somatostatin genes,
and transactivation of these genes has been con®rmed in
vitro (Sander et al., 1997).
Thus, although the phenotypes of SeyNeu and Pax6 knock-
out largely overlap, there are some important differences.
First, Pax6 knock-out mice do not form a-cells whereas in
SeyNeu mutant mice the number of a-cells is reduced.
Secondly, in SeyNeu mutant mice all endocrine cell types
seem to be affected whereas in Pax6 knock-out mice only
a-cells are missing.
5. The pancreas of Pax4 knock-out mice
Homozygous Pax4-de®cient new-borns are indistinguish-
able from their litter mates, but die 3±5 days after birth. The
pancreas of Pax4 mutant mice is normal in size and weight
but mature insulin- and somatostatin-producing cells are
absent (Sosa-Pineda et al., 1997). Nevertheless, insulin-
producing cells can be detected during the early stages of
pancreas development (E10.5), but the expression levels of
insulin and Pdx1 are drastically decreased by E15.5 (Fig. 1).
At this stage the pancreas of Pax4 mutant mice contains
cells expressing b-cell markers such as amylin, Islet1,
Nkx6.1, Nkx2.2 and Pdx1. However, no mature b-cell
marker, like Nkx6.1 or Pdx1, can be detected, con®rming
the absence of mature b-cells in new-born Pax42/2 mice
(Sosa-Pineda et al., 1997; Sosa-Pineda, pers. commun.).
Furthermore, in new-born Pax42/2 mice the number of
glucagon-producing cells is signi®cantly increased
compared to heterozygous litter mates and they appear to
be clustered atypically in the core of an islet-like structure
(Sosa-Pineda et al., 1997). This relative increase in gluca-
gon expressing cells suggests that endocrine progenitors
instead of differentiating into b-/d-cell precursors take on
an a-cell fate. The apparent phenotype in new-borns
suggests that insulin-producing b- and somatostatin-produ-
cing d-cells have been replaced by glucagon-producing a-
cells, supporting the hypothesis that b- and d-cells are
derived from a common lineage (Apert et al., 1988; Teitel-
man et al., 1993; Guz et al., 1995). The detailed analysis of
the progression of the Pax4 knock-out phenotype reveals
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that the mutants are able to form immature b-cells which
subsequently fail to differentiate into mature b-cells, but
alternatively acquire a-cell characteristics.
Finally, mice lacking both Pax4 and Pax6 fail to develop
mature endocrine cells entirely, indicating that both Pax4
and Pax6 are required for endocrine development in the
pancreas (St-Onge et al., 1997).
6. The role of PAX4, PAX6 and other transcription
factors in pancreas development
In addition to PAX4 and PAX6, a number of transcription
factors, ISL1, PDX1, BETA2/NEUROD, NKX6.1, and
NKX2.2, have been implicated in pancreas development
and the differentiation of endocrine cells. Although it is
still dif®cult to assign speci®c functions to some of these
factors, the emerging picture suggests that there are three
levels to endocrine development. The ®rst step involves the
generation of endocrine progenitors which are able to differ-
entiate into all four endocrine cell types, a-, b-, d-, and PP-
cells, within the pancreatic epithelium. In a second step
these pluripotent endocrine progenitors become restricted
to either the b-/d- or a-/PP-cell fate. In a third and ®nal
step, precursor cells which are already committed to the
b- or d-cell fate develop in either b- or d-cells. The differ-
ention pathway of the a- and PP-cell lineage is less clear. It
is not understood if a- and PP-cells develop from a common
precursor or separately develop directly from pluripotent
endocrine progenitors (Fig. 2).
Pluripotent endocrine progenitor cells are thought to arise
from a duodenal portion of the foregut which is located just
posterior to the developing stomach. Little is known about
the factors involved in the formation of endocrine progeni-
tor cells, with the exception of ISL1, a LIM homeodomain
protein. Isl1-de®cient mice completely lack all endocrine
islet cells, indicating a function for Isl1 in the generation
of endocrine progenitor cells (Ahlgren et al., 1997).
However, Isl1 is also required for exocrine cell differentia-
tion in the dorsal bud. Isl1-de®cient mice lack the dorsal bud
mesenchyme and fail to develop exocrine tissue in the
dorsal bud. Therefore, Isl1 is not only speci®cally required
for endocrine, but also exocrine development (Pfaff et al.,
1996; Ahlgren et al., 1997). Consequently, early differentia-
tion of the embryonic gut epithelium towards the endo- or
exocrine lineages requires additional factors acting down-
stream of Isl1, which would subsequently specify the endo-
crine and exocrine lineage (Fig. 2).
The area of the foregut which is thought to give rise to the
pluripotent endocrine progenitor can be identi®ed with the
help of molecular markers before morphological signs of
pancreas development become apparent. The pancreatic
epithelium is marked by a lack of sonic hedgehog expres-
sion (a secreted factor in¯uencing polarity of the developing
gut) (Ahlgren et al., 1997), which is detected in the endo-
derm just anterior and posterior to pancreatic epithelium,
and the restricted expression of Pdx1 (Ohlsson et al.,
1993; Jonsson et al., 1994; Of®eld et al., 1996). Although
Pdx1 expression speci®es this early pancreatic epithelium, it
is not required for the early differention of insulin- and
glucagon-producing cells. It is more likely that Pdx1 is
involved in the proliferation of endocrine progenitor cells
or, alternatively, in the proliferation of already differentiated
precursors expressing insulin and glucagon (Fig. 2) (Jonsson
et al., 1994; Ahlgren et al., 1998).
Once endocrine progenitors are established, Pax genes
play a crucial role in the differentiation of speci®c endocrine
cell lineages and even speci®c endocrine cell types. Loss of
Pax4 function results in a complete lack of the b- and d-cell
lineage (Sosa-Pineda et al., 1997). This suggests that after
the establishment of a pluripotent endocrine progenitor
which has the potential to develop into all four endocrine
cell types, those cells that express Pax4 adopt a more
restricted cell fate, i.e. only insulin- and somatostatin-produ-
cing cells (Fig. 2). In fact, in the absence of Pax4 function
endocrine progenitors are unable to fully differentiate into
b- or d- cells and instead convert to an a-cell fate.
In contrast, Pax6 is speci®cally involved in the differen-
tiation of a-cells (St-Onge et al., 1997). Whether a-cells
directly differentiate from a pluripotent endocrine progeni-
tor or a precursor that is already restricted to the a- and PP-
cell fate is presently unclear (Fig. 2). In either case, addi-
tional factors are required for the differentiation of g-cells
and possibly for the differentiation of an a-/PP-precursor.
There is further evidence that Pax6 function is not just
required for a-cell differentiation but that it is also involved
in the proliferation of all endocrine cells (Fig. 2). Although
the Pax6-de®cient pancreas completely lacks glucagon-
producing cells, no increase in cell number of other cell
types has been observed. Moreover, in SeyNeu mutants all
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Fig. 2. Model for endocrine cell differentiation based on functional analysis
of developmental control genes. a, glucagon-producing cell; b, insulin-
producing cell; d, somatostatin-producing cell; PP, pancreatic polypep-
tide-producing cell.
Pax6 expressing endocrine cell types (a-, b-, g-, and PP-
cells) are reduced in number indicating their inability to
proliferate properly (Sander et al., 1997). A role for Pax6
in the general proliferation of endocrine cells is also
supported by the phenotype of double-mutant Pax4/Pax6
mice which seem to lack all endocrine cells (St-Onge et
al., 1997). Since Pax4-de®cient mice only lack b- and d-
cells and Pax6-de®cient mice only lack a-cells, it is not
clear why PP-cells are missing as well.
The cell type-restricted basic helix-loop-helix (bHLH)
transcription factor BETA2/NEUROD is likely to be
involved in the proliferation rather than the differentiation
of endocrine cells. Beta2/NeuroD is expressed in all endo-
crine cells of the pancreatic epithelium and targeted gene
disruption results in mice suffering severe diabetes and
dying shortly after birth (Lee et al., 1995; Naya et al.,
1997). Although the proliferation of insulin-producing
cells seems to be most strongly affected, all endocrine cell
types are signi®cantly reduced in number, suggesting a role
for BETA2/NEUROD not only in the differentiation of b-
cells but in the general proliferation of endocrine cells.
Nkx6.1, a member of the NK homeobox family, is widely
expressed in the pancreatic epithelium during the early
stages of pancreas development, whereas in new-borns
Nkx6.1 expression is restricted to b-cells. Knock-out data
reveal a severe reduction in insulin-producing cells, but
normal numbers of other islet cell types, indicating an
important role for Nkx6.1 in b-cell differentiation (Sander
et al., 1998).
NKX2.2 also belongs to the NK2 homeodomain family of
transcription factors. Similar to Nkx6.1, early expression of
Nkx2.2 can be detected in all endocrine cell types. As devel-
opment proceeds, Nkx2.2 becomes restricted to b-cells,
most a-cells and PP-cells but is excluded from mature
somatostatin-producing d-cells. Nkx2.2 inactivation is asso-
ciated with arrested b-cell differentiation resulting in
complete absence of insulin-producing cells (Sussel et al.,
1998). Additionally, a severe reduction in glucagon-produ-
cing cells and a slight reduction in pancreatic polypeptide-
producing cells is observed, whereas somatostatin-produ-
cing cells remain unaffected. Late markers, including insu-
lin, glucose transporter 2 and glucokinase, indicative of b-
cell maturity are not expressed in the mutant islet, whereas
early markers such as Pdx1 and Pax6 are present. These
results indicate that Nkx2.2-de®cient mice can initiate b-
cell development but these cells are unable to terminally
differentiate into functional hormone-producing cells (Fig.
2).
7. Conclusions
The generation and analysis of mouse mutants has led to
the identi®cation of various transcription factors that play
important roles in pancreas development. Some of these
factors, ISL1, PDX1, and BETA2/NEUROD, affect the
development of all endocrine cell types, whereas other
factors seem to speci®cally affect only certain lineages.
Whereas Pax4 is involved in the differentiation of b- and
d-cells, Pax6 and Nkx2.2 speci®cally affect the development
of a- and b-cells, respectively. These differences in pheno-
type suggest that there are at least three levels to endocrine
differentiation (Fig. 2). In the ®rst step endocrine progeni-
tors are generated which have the capacity to differentiate
into all four endocrine cell types. Although Isl1 is involved
in the generation of endocrine progenitors it also affects
exocrine development. Therefore, it is likely that there are
additional, yet to be identi®ed, factors that specify the
generation of pluripotent endocrine progenitors. In a second
step, these pluripotent progenitors subsequently commit to
either the b-/d- or the a-/PP-cell lineage. The best evidence
for such a binary decision that results in precursor cells
already committed to the b-/d-lineage is the lack of b-
and d-cells in Pax4 mutant mice. However, it remains to
be determined if there are precursor cells which, in a similar
manner, are committed to the a-/PP-lineage. In the ®nal
step, precursor cells which are committed to the b-/d- line-
age differentiate into either b- or d-cells. Factors that are
required for this ®nal differentiation step from the b-/d-
precursor to the mature b-cell are NKX2.2 and possibly
NKX6.1, whereas PAX6 is required for the ®nal differentia-
tion of a-cells. Factors which are speci®cally required for
the ®nal differentiation of d- and PP-cells have yet to be
identi®ed.
Although the studies outlined here have accumulated
signi®cant knowledge, the real power of these observations
lies in their potential application to diseases involving
pancreatic dysfunction. In particular, it appears that the
highly in¯uential role of the Pax genes in the developing
embryo encompasses the process of proliferation and differ-
entiation of the endocrine pancreas. This potential of Pax
genes to trigger proliferation and differentiation is enor-
mously valuable with regard to the regenerative capacity
of the adult pancreas. Current thinking suggests the exciting
idea that developmental control genes contribute to a
genetic network where genes are interconnected by regula-
tory feedback loops. Once an entity of the network is active
it results in triggering the mature phenotype. Novel thera-
peutics that exploit these loops are becoming reality for
diseases such as diabetes. Among different approaches,
there are innovative attempts to regenerate insulin-produ-
cing b-cells using Pax, Pdx1 and other developmental
control genes from pancreatic or embryonal stem cells.
The successful regeneration of cellular populations repre-
sents an ideal opportunity towards novel therapeutics for a
growing patient population.
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